Home › Funds › SOFTBANK GROUP CORP. › NMRA
SOFTBANK GROUP CORP. position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
SOFTBANK GROUP CORP. reported holding 6,090,301 shares of NMRA (NEUMORA THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$10.4M, representing 0.06% of its reported portfolio and ranking #24 among its reported holdings. SOFTBANK GROUP CORP. has disclosed NMRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SOFTBANK GROUP CORP.'s NMRA position evolved
SOFTBANK GROUP CORP. first disclosed a stake in NMRA in Q3 2023 at 7,646,916 shares (US$107.9M). The position peaked in Q4 2023 at 7,646,916 shares, worth US$130.4M. Across 12 filings, SOFTBANK GROUP CORP. increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 6,090,301 shares valued at US$10.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 7.65M | $107.90M | New |
| Q4 2023 | 7.65M | $130.38M | Hold |
| Q1 2024 | 7.65M | $105.15M | Hold |
| Q2 2024 | 7.65M | $75.17M | Hold |
| Q3 2024 | 7.55M | $99.69M | Reduce |
| Q4 2024 | 6.54M | $69.34M | Reduce |
| Q1 2025 | 6.54M | $6.54M | Hold |
| Q2 2025 | 6.54M | $4.80M | Hold |
| Q3 2025 | 6.54M | $11.90M | Hold |
| Q4 2025 | 6.43M | $11.51M | Reduce |
| Q1 2026 | 6.09M | $11.88M | Reduce |
| Q2 2026 | 6.09M | $10.35M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NMRA and 13F data
NMRA (NEUMORA THERAPEUTICS INC.) is a Health Care company. 22 other funds we track also report a position in NMRA — the largest reported positions include MIC Capital Management UK LLP (US$7.6M), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (US$5.6M), ICONIQ Capital, LLC (US$4.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NMRA
- MIC Capital Management UK LLP 4.46M sh · $7.58M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 3.31M sh · $5.63M · Q2 2026
- ICONIQ Capital, LLC 2.56M sh · $4.35M · Q2 2026
- Lunate Capital Ltd 2.12M sh · $3.61M · Q2 2026
- Boxer Capital Management, LLC 2.00M sh · $3.40M · Q2 2026
- JOHNSON & JOHNSON 1.85M sh · $3.14M · Q2 2026
More on SOFTBANK GROUP CORP.
FAQ
How long has SOFTBANK GROUP CORP. held NMRA?
SOFTBANK GROUP CORP. has disclosed NMRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is SOFTBANK GROUP CORP.'s current position in NMRA?
As of Q2 2026, SOFTBANK GROUP CORP. holds 6.09M shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $10.35M, representing 0.06% of its reported portfolio and ranking #24.
Has SOFTBANK GROUP CORP. been buying or selling NMRA?
In the latest 13F filing (Q2 2026), SOFTBANK GROUP CORP. held unchanged its position in NMRA. The position peaked in Q4 2023 at 7.65M shares.
Which other funds hold NMRA?
Other major institutional holders of NMRA include MIC Capital Management UK LLP, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, ICONIQ Capital, LLC, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.